Compare ADMA Biologics Inc (ADMA) vs Oxford Lane Capital Corp (OXLC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs Oxford Lane Capital Corp — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while Oxford Lane Capital Corp trades at $9.38 (market cap $909.61M). The key difference: ADMA Biologics Inc is far larger — about 2.4× Oxford Lane Capital Corp's market cap, and Oxford Lane Capital Corp pays a 25.76% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.
| ADMA | OXLC | |
|---|---|---|
Market Cap | $2.22B | $909.61M |
Sector | Health | Financials |
52-Week High | $20.38 | $18.75 |
52-Week Low | $7.60 | $8.15 |
Enterprise Value | $2.29B | — |
Dividend Yield | — | 25.76% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Oxford Lane Capital Corp
Oxford Lane Capital Corp. is a non-diversified, closed-end management investment company. Its primary investment objective is to achieve high current income, with a secondary objective of capital appreciation. The company primarily invests in equity and junior debt tranches of collateralized loan obligations (CLOs), which are pools of corporate loans. OXLC is known for its high-yield distribution policy and provides investors with leveraged exposure to the CLO market.
Read more on OXLC →
